|
1
|
Dinchuk JE, Focht RJ, Kelley JA, Henderson
NL, Zolotarjova NI, Wynn R, Neff NT, Link J, Huber RM, Burn TC, et
al: Absence of post-translational aspartyl beta-hydroxylation of
epidermal growth factor domains in mice leads to developmental
defects and an increased incidence of intestinal neoplasia. J Biol
Chem. 277:12970–12977. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Treves S, Feriotto G, Moccagatta L,
Gambari R and Zorzato F: Molecular cloning, expression, functional
characterization, chromosomal localization and gene structure of
junctate, a novel integral calcium binding protein of
sarco(endo)plasmic reticulum membrane. J Biol Chem.
275:39555–39568. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ince N, de la Monte SM and Wands JR:
Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is
associated with malignant transformation. Cancer Res. 60:1261–1266.
2000.PubMed/NCBI
|
|
4
|
Maeda T, Taguchi K, Aishima S, Shimada M,
Hintz D, Larusso N, Gores G, Tsuneyoshi M, Sugimachi K, Wands JR
and de la Monte SM: Clinicopathological correlates of aspartyl
(asparaginyl) beta-hydroxylase over-expression in
cholangiocarcinoma. Cancer Detect Prev. 28:313–318. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lavaissiere L, Jia S, Nishiyama M, de la
Monte S, Stern AM, Wands JR and Friedman PA: Overexpression of
human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular
carcinoma and cholangiocarcinoma. J Clin Invest. 98:1313–1323.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sepe PS, Lahousse SA, Gemelli B, Chang H,
Maeda T, Wands JR and de la Monte SM: Role of the
aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell
motility. Lab Invest. 82:881–891. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dinchuk JE, Henderson NL, Burn TC, Huber
R, Ho SP, Link J, O'Neil KT, Focht RJ, Scully MS, Hollis JM, et al:
Aspartyl beta-hydroxylase (Asph) and an evolutionarily conserved
isoform of Asph missing the catalytic domain share exons with
junctin. J Biol Chem. 275:39543–39554. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang H, Song K, Xue T, Xue XP, Huyan T,
Wang W and Wang H: The distribution and expression profiles of
human Aspartyl/Asparaginyl beta-hydroxylase in tumor cell lines and
human tissues. Oncol Rep. 24:1257–1264. 2010.PubMed/NCBI
|
|
9
|
Xue T, Su J, Li H and Xue X: Evaluation of
HAAH/humbug quantitative detection in the diagnosis of
hepatocellular carcinoma. Oncol Rep. 33:329–337. 2015.PubMed/NCBI
|
|
10
|
Huyan T, Li Q, Ye LJ, Yang H, Xue XP,
Zhang MJ, Huang QS, Yin DC and Shang P: Inhibition of human natural
killer cell functional activity by human aspartyl β-hydroxylase.
Int Immunopharmacol. 23:452–459. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xue T, Xue XP, Huang QS, Wei L, Sun K and
Xue T: Monoclonal antibodies against human aspartyl (asparaginyl)
beta-hydroxylase developed by DNA immunization. Hybridoma
(Larchmt). 28:251–257. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sharp PM and Li WH: The codon adaptation
index-a measure of directional synonymous codon usage bias, and its
potential applications. Nucleic Acids Res. 15:1281–1295. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Q, Mei Q, Huyan T, Xie L, Che S, Yang
H, Zhang M and Huang Q: Effects of simulated microgravity on
primary human NK cells. Astrobiology. 13:703–714. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xian ZH, Zhang SH, Cong WM, Yan HX, Wang K
and Wu MC: Expression of aspartyl beta-hydroxylase and its
clinicopathological significance in hepatocellular carcinoma. Mod
Pathol. 19:280–286. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luo Y, Terkawi MA, Jia H, Aboge GO, Goo
YK, Cao S, Li Y, Yu L, Ooka H, Kamyingkird K, et al: A double
antibody sandwich enzyme-linked immunosorbent assay for detection
of secreted antigen 1 of Babesia microti using hamster model. Exp
Parasitol. 130:178–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maeda T, Sepe P, Lahousse S, Tamaki S,
Enjoji M, Wands JR and de la Monte SM: Antisense
oligodeoxynucleotides directed against aspartyl (asparaginyl)
beta-hydroxylase suppress migration of cholangiocarcinoma cells. J
Hepatol. 38:615–622. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee JH: Overexpression of humbug promotes
malignant progression in human gastric cancer cells. Oncol Rep.
19:795–800. 2008.PubMed/NCBI
|
|
18
|
Baneyx F: Recombinant protein expression
in Escherichia coli. Curr Opin Biotechnol. 10:411–421. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brake AJ, Merryweather JP, Coit DG,
Heberlein UA, Masiarz FR, Mullenbach GT, Urdea MS, Valenzuela P and
Barr PJ: Alpha-factor-directed synthesis and secretion of mature
foreign proteins in Saccharomyces cerevisiae. Proc Natl Acad Sci
USA. 81:4642–4646. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oppenheim DE, Spreafico R, Etuk A, Malone
D, Amofah E, Peña-Murillo C, Murray T, McLaughlin L, Choi BS, Allan
S, et al: Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells
from colorectal cancer patients irrespective of chemotherapy. Br J
Cancer. 110:1221–1227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nimmerjahn F and Ravetch JV: Divergent
immunoglobulin g subclass activity through selective Fc receptor
binding. Science. 310:1510–1512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schneider-Merck T, van Bueren JJ Lammerts,
Berger S, Rossen K, van Berkel PH, Derer S, Beyer T, Lohse S,
Bleeker WK, Peipp M, et al: Human IgG2 antibodies against epidermal
growth factor receptor effectively trigger antibody-dependent
cellular cytotoxicity but, by contrast to IgG1, only by cells of
myeloid lineage. J Immunol. 184:512–520. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Y, Wang Y, Zhuang Y, Zhou F and Huang
L: Mifepristone increases the cytotoxicity of uterine natural
killer cells by acting as a glucocorticoid antagonist via ERK
activation. PLoS One. 7:e364132012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Panacea Global, . A New and Sensitive
Diagnostic Test for the Detection of Breast Cancer-BC Detect.
http://www.panaceaglobalinc.com/edit/files/pdfs/bc_detect/35-bcd-pub.pdf
|
|
25
|
Panacea Global, . A New and Sensitive
Diagnostic Test for the Detection of Colorectal Cancer-CC Detect.
http://www.panaceaglobalinc.com/edit/files/pdfs/cc_detect/36ccd-pub.pdf
|
|
26
|
Panacea Global, . A New and Sensitive
Diagnostic Test for the Detection of Lung Cancer-LC Detect.
http://www.panaceaglobalinc.com/edit/files/pdfs/lc_detect/37-lcd-pub.pdf
|
|
27
|
Panacea Global, . A New and Sensitive
Diagnostic Test for the Detection of Prostate Cancer-PC Detect.
http://www.panaceaglobalinc.com/edit/files/pdfs/pc_detect/38-pcd-pub.pdf
|
